ALTERED DISTRIBUTION OF DEBRISOQUINE OXIDATION PHENOTYPES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS

被引：48

作者：

BAER, AN

MCALLISTER, CB

WILKINSON, GR

WOOSLEY, RL

PINCUS, T

机构：

[1] VANDERBILT UNIV, DEPT MED, NASHVILLE, TN 37240 USA

[2] VANDERBILT UNIV, DEPT PHARMACOL, NASHVILLE, TN 37240 USA

[3] VET ADM MED CTR, NASHVILLE, TN 37203 USA

来源：

ARTHRITIS AND RHEUMATISM | 1986年 / 29卷 / 07期

关键词：

D O I：

10.1002/art.1780290705

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：843 / 850

页数：8

共 43 条

[1] IMPAIRMENT OF HEPATIC DRUG OXIDATION BY PROPOXYPHENE
ABERNETHY, DR
GREENBLATT, DJ
STEEL, K
SHADER, RI
[J]. ANNALS OF INTERNAL MEDICINE, 1982, 97 (02) : 223 - 224
[2] METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER
AYESH, R
IDLE, JR
RITCHIE, JC
CROTHERS, MJ
HETZEL, MR
[J]. NATURE, 1984, 312 (5990) : 169 - 170
[3] FURTHER EVIDENCE FOR THE LACK OF ASSOCIATION BETWEEN ACETYLATOR PHENOTYPE AND SYSTEMIC LUPUS-ERYTHEMATOSUS
BAER, AN
WOOSLEY, RL
PINCUS, T
[J]. ARTHRITIS AND RHEUMATISM, 1986, 29 (04): : 508 - 514
[4] BOOBIS AR, 1983, MOL PHARMACOL, V23, P474
[5] BRANCH RA, 1985, CLIN RES, V33, pA527
[6] CARR K, 1978, BRIT J CLIN PHARMACO, V6, P421, DOI 10.1111/j.1365-2125.1978.tb04606.x
[7] CHENG KC, 1984, DRUG METAB DISPOS, V12, P222
[8] CONNEY AH, 1982, CANCER RES, V42, P4875
[9] MULTIPLE TESTING OF HYPOTHESES IN COMPARING 2 GROUPS
CUPPLES, LA
HEEREN, T
SCHATZKIN, A
COLTON, T
[J]. ANNALS OF INTERNAL MEDICINE, 1984, 100 (01) : 122 - 129
[10] VARIANTS OF HUMAN MICROSOMAL-ENZYMES
DAVIES, DS
BOOBIS, AR
[J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1983, 11 (04) : 459 - 460